phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor
本文档由 g97p0e1sx 分享于2017-03-02 02:45
phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor
下载文档
收藏
打印
君,已阅读到文档的结尾了呢~~